Company News

SmartBone® has featured on the Italian economic newspaper “Il Sole 24 Ore”

January 26, 2018
SmartBone® - il sole 24 ore
Il Sole 24 Ore, an Italian national daily business newspaper, talks for the second time about Smartbone® in the article titled “SmartBone®: the next frontier of bone regeneration” on Friday January 26th, 2018. The newspaper describes the big potential of tissue engineering and the success of IBI in this field thanks to the innovative bone...

IBI SA story featured in the german magazine Wirtschaftsforum

September 14, 2017
IBI SA Pertici Perale
The story of IBI SA has been recently featured in the german magazine Wirtschaftsforum. From the beginning to the future projects, Gianni Pertici – IBI CEO and founder – and Giuseppe Perale – IBI President and founder – present their company and its groundbreaking product SmartBone®: an innovative bone substitute especially developed for the regenerative...

IBI SA ON TV – RTS Radio Télévision Suisse (VIDEO)

September 14, 2017
IBI SA RTS TV
  Doctor Gianni Pertici CEO and founder of IBI SA was recently interviewed by RTS (Radio Télévision Suisse) during the main news “Le 19.30” on September 11th, 2017. The main focus of the dossier was the importance of biomedical companies to the economy of Ticino, the swiss region where IBI SA is based. Thanks to...

Double live surgery with SmartBone®

September 15th, 2017
SmartBone® Live surgery
The 15th of September in Porto Mantovano (Italy) from 8.30 am, Dr. Roberto Ghiretti will perform a double live surgery using SmartBone® and SmartBone® On Demand™. IBI gives the possibility to assist both live surgeries preceded by a SmartBone® presentation. Specifically during the day you will attend: 1 SmartBone® presentation 1 cyst treated with SmartBone® 1 SmartBone® On Demand augmentation...

Mandibular cystic neoformation treated with SmartBone® – live surgery

July 27th, 2017
The 27th of July in Porto Mantovano (Italy), Dr. Roberto Ghiretti and Dr. Emanuele Ambu will perform a very special surgery: a mandibular cystic neoformation (odontogenus glandular cysts) from 35 to 45 treated with SmartBone®. Below you can find how Dr. Ghiretti and Dr. Ambu will proceed: Root canal therapy of 33, 32 e 43 Cystic...

Large maxillofacial reconstruction case with SmartBone® on Demand™

July 7, 2017
SmartBone® On Demand™
In June 2017, SmartBone® on Demand™  engaged successfully in an enormously complex maxillofacial surgical challenge. The innovative bone substitute designed by the engineers of Industrie Biomediche Insubri SA (IBI-SA) was, in fact, the main star in a severe large maxillo-facial reconstruction case. Thanks to the cooperation between IBI-SA and the renowned Azienda Ospedaliera Universitaria Careggi...

* Important Communication *

--
IBI would like to inform its customers and distributors that a misprint is present in the SmartBone® package insert: the sterilization method of the Medical Device implies the use of ethylene oxide instead of acetylene oxide. IBI regrets for the inconvenience and will promptly take care of...

SmartBone® On Demand™ reconstruction of a large cranial defect

May 31, 2016
In May 2016, SmartBone® on Demand™  engaged successfully in a complex cranial surgical challenge. The innovative bone substitute designed by Industrie Biomedriche Insubri SA was, in fact, the main star in a complex large cranial reconstruction case. Thanks to the cooperation between IBI-SA and the renowned Ospedale Caldarelli in Napoli by Dr. Enzo Facciuto, a revolutionary approach was...

SmartBonePep® a Bio-hybrid composite bone graft

April 6, 2016
smartbonepep
Visit the website! Industrie Biomediche Insubri SA (IBI) in a collaboration with The Pharmaceutical and Biomedical Technologies laboratory, within the Institute CIM for Sustainable Innovation of the University of Applied Sciences and Arts of Southern Switzerland (SUPSI) (www.supsi.ch/icimsi), and Corticalis AS (www.corticalis.com), a Norwegian R&D company focused on bone regenerative technologies and biomaterials, won the Eurostars Project –...

Subscribe to our newsletter